Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An update from Diaceutics ( (GB:DXRX) ) is now available.
Diaceutics PLC announced it will release its audited final results for the year ending December 31, 2024, on May 13, 2025. The company will hold webinars for analysts and investors on the same day, providing insights into its financial performance and strategic direction, which could impact its market positioning and stakeholder interests.
More about Diaceutics
Diaceutics PLC is a leading technology and solutions provider in the pharma and biotech industry, offering end-to-end commercialization solutions for precision medicines. Their services include data analytics, scientific, and advisory services, facilitated by their platform DXRX – The Diagnostics Network ®.
YTD Price Performance: -0.22%
Technical Sentiment Signal: Sell
Current Market Cap: $133M
For detailed information about DXRX stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue